Sales rise 41.41% to Rs 77.38 crore
Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales77.3854.72 41 OPM %13.6919.66 -PBDT6.0310.67 -43 PBT5.5610.01 -44 NP4.5914.43 -68Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "dr reddy's laboratory , dr reddy , drl pharma sector")
 "UEFA Champions League")
 "S Jaishankar, Jaishankar, Richard Marles")
 "Fiscal deficit")
 "Marut drones founder")
